학술논문
An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure
Document Type
Article
Author
Source
In: Circulation Research . (Circulation Research, 1 March 2013, 112(5):816-825)
Subject
Language
English
ISSN
00097330
15244571
15244571